Cooper Cancer Institute is a clinical research site located in Voorhees Township, New Jersey, United States 08043.
Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.
Cooper Cancer Institute has participated in 9 clinical trials.
Therapeutic areas: Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms.
Sponsors: Novartis, NCIC Clinical Trials Group, Morphotek.
Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Cooper Cancer Institute has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Cooper Cancer Institute has 9 clinical trials on record. Their work covers Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms.
Yes — Cooper Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.